Keyphrases
Cystic Fibrosis
100%
Asthma
74%
Lung Transplantation
43%
Primary Ciliary Dyskinesia
32%
Pediatric Lung Transplantation
27%
Pediatric
20%
Cystic Fibrosis Transmembrane Conductance Regulator
20%
Inhaled Corticosteroids
19%
Preschool children
18%
Forced Expiratory Volume in 1 Second (FEV1)
17%
Lung Function
16%
Lung
16%
Wheezing
15%
Childhood Asthma
14%
Asthma Exacerbation
12%
Clinical Trials
11%
Airway
11%
Transplantation
11%
Placebo
11%
United States
11%
Epithelial Sodium Channel (ENaC)
11%
Allergic Diseases
10%
Allergy
10%
Children with Asthma
10%
Severe Asthma
10%
Pediatric Asthma
9%
Allergen
9%
Pediatric Patients
9%
Risk Factors
9%
High Risk
9%
Confidence Interval
9%
Young children
9%
Recurrent Wheezing
8%
Atopy
8%
Asthma Control
8%
Pulmonary Function
8%
Gene Transfer
8%
Allergic Rhinitis
7%
Cystic Fibrosis Lung Disease
7%
Airway Epithelial Cells
7%
Airway Inflammation
7%
Genotype
7%
Azithromycin
7%
Pseudomonas Aeruginosa (P. aeruginosa)
7%
Allergic Asthma
7%
Vitamin D
7%
Fluticasone Propionate
7%
Bronchiolitis Obliterans
7%
COVID-19
6%
Inflammation
6%
Virus
6%
Sudden Infant Death Syndrome
6%
Recurrent Wheeze
6%
Pancreatic Insufficient
6%
Persistent Asthma
6%
Cystic Fibrosis Foundation
5%
Lung Disease
5%
Bronchiolitis Obliterans Syndrome
5%
Omalizumab
5%
Severe Asthma Research Program
5%
Heart-lung
5%
Epithelial Cells
5%
Rebreathing
5%
Clinical Outcomes
5%
Early childhood
5%
Sublingual Immunotherapy
5%
Asthma Severity
5%
Oral Corticosteroids
5%
Post-transplant Lymphoproliferative Disorder
5%
Cilia
5%
Body Mass Index
5%
Moderate to Severe
5%
Acute Rejection
5%
Asthma Symptoms
5%
Ivacaftor
5%
Respiratory Outcomes
5%
Prematurity
5%
Respiratory Syncytial Virus
5%
American Thoracic Society
5%
Medicine and Dentistry
Cystic Fibrosis
79%
Pediatrics
58%
Asthma
54%
Lung Transplantation
51%
Lung
45%
Diseases
23%
Primary Ciliary Dyskinesia
21%
Transplantation
19%
Wheeze
17%
Silo-Filler's Disease
14%
Patient with Cystic Fibrosis
12%
Placebo
12%
Preschooler
11%
Infection
11%
Adolescence
11%
Bronchiolitis Obliterans
10%
Cystic Fibrosis Transmembrane Conductance Regulator
9%
Clinical Trial
9%
Forced Expiratory Volume
9%
Breathing
8%
Sudden Infant Death Syndrome
8%
Respiratory Disease
7%
Ivacaftor
7%
Diagnosis
7%
Prematurity
7%
Toddlers
6%
Glucose Tolerance
6%
Pediatrics Patient
6%
Pseudomonas aeruginosa
6%
Azithromycin
5%
Vitamin D
5%
Lung Function
5%
Rebreathing
5%
Nitric Oxide
5%
Sensitization
5%
Pulmonary Hypertension
5%
COVID-19
5%
Systematic Review
5%